
Neo Performance Materials raised its 2026 Adjusted EBITDA guidance 38% to $140-150M, sending shares up 12%. Pricing strength in hafnium, gallium and rare earths drove the revision. The Greenland Mines deal adds a long-term supply option.
Neo Performance Materials (TSX: NEO) shares jumped 12.3% to C$42.55 on Tuesday, making the TSX top-gainer list after the company lifted its full-year 2026 Adjusted EBITDA guidance by 38% at the midpoint.
The Toronto-based critical materials producer now expects Adjusted EBITDA of $140 million to $150 million, up from a prior range of $100 million to $110 million. That midpoint of $145 million would be roughly 90% above the $76 million the company reported for full-year 2025.
The revision reflects pricing strength across Neo's critical materials portfolio. Prices for hafnium, gallium, and rare earth elements stayed elevated through the first half of 2026, supported by tight global supply and sustained end-market demand. The company said all three business segments – Magnequench, Chemicals & Oxides, and Rare Metals – contributed to the stronger outlook.
Neo manufactures magnetic powders, rare earth magnets, specialty chemicals, and metals used in electric vehicles, wind turbines, and defense applications. The company operates facilities in Canada, Estonia, China, Germany, Thailand, and the UK.
The Greenland Mines Deal
In May, Neo announced that its subsidiary Neo North Star Holdings had entered into an agreement to transfer its stake in Neo North Star Resources to Greenland Mines Ltd. The deal values the Sarfartoq Carbonatite Complex in Southwest Greenland at US$35 million, paid in US$20 million cash and US$15 million in Greenland Mines shares. Neo North Star currently owns 43.69% of NNSR.
The structure lets Greenland Mines take the lead on developing the Sarfartoq project while Neo retains an equity interest. The arrangement does not affect a separate memorandum of understanding for an offtake agreement covering up to 60% of the ore or mineral concentrate from the project.
Sector Read-Through
The guidance raise is a direct read-through for rare earth and critical materials producers. Neo's pricing commentary – hafnium, gallium, and rare earths holding elevated levels – suggests the supply-demand imbalance in specialty metals is persisting into mid-2026. That dynamic benefits producers with existing processing capacity and long-term offtake agreements.
For investors tracking the space, the key question is whether the pricing strength is structural or cyclical. Neo's midpoint guidance implies a 90% year-over-year EBITDA jump, which is a large swing for a company that was already profitable. If end-market demand for rare earth magnets and specialty metals holds, the stock's current 12x forward EBITDA multiple (at the new midpoint) may look cheap relative to specialty-chemical peers trading at 15-18x.
The risk is that the pricing spike reflects temporary supply disruptions rather than a lasting shift. Gallium and germanium prices surged after China's export controls in 2023, then partially retraced. Neo's guidance assumes the current pricing environment persists through year-end. A reversal in hafnium or rare earth prices would compress the multiple quickly.
Neo shares have gained roughly 30% year-to-date. The stock trades near C$42.55, with a day's high of C$43.03.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.